Cervical cancer screening at a tertiary care center in Rwanda

George Ruzigana, Lisa Bazzet-Matabele, Stephen Rulisa, Allison N. Martin, Rahel G Ghebre

Research output: Contribution to journalArticle

Abstract

In limited resource settings such as Rwanda, visual inspection with acetic acid (VIA) is the primary model for cervical cancer screening. The objective of this study was to describe clinical characteristics and outcomes for women presenting for cervical cancer screening. A prospective, observational study was conducted between September 2015 and February 2016 at Kigali University Teaching Hospital (CHUK). Women referred to the VIA clinic were enrolled and completed a semi-structured questionnaire. During the six-month study period, 150 women were enrolled and evaluated with VIA followed by colposcopy directed biopsy for VIA positive. The median age was 42 years (IQR 36–49). Only 20 (13.3%) asymptomatic women presented for screening exam, whereas 126 (84%) were symptomatic. Among symptomatic patients, more than one-third had never had a speculum exam prior to referral (n = 43). Twenty-two (14.7%) women were VIA positive, and 8 (5.3%) had lesions suspicious for cancer, while 120 (80%) were found to be VIA negative. Among women undergoing biopsy (n = 30), 11 were normal (36.7%), 5 cases showed CIN 1 (16.6%), 4 cases showed CIN 2 (13.3%), 2 cases showed CIN 3 (6.7%) and 8 were confirmed cervical cancers (26.7%). In Rwanda, VIA is the current method for cervical cancer screening. In this study, few asymptomatic patients presented for cervical cancer screening. Increasing knowledge about cervical cancer screening and expanding access are key elements to improving cervical cancer control in Rwanda.

Original languageEnglish (US)
Pages (from-to)13-16
Number of pages4
JournalGynecologic Oncology Reports
Volume21
DOIs
StatePublished - Aug 1 2017

Fingerprint

Rwanda
Early Detection of Cancer
Tertiary Care Centers
Uterine Cervical Neoplasms
Acetic Acid
Biopsy
Colposcopy
Surgical Instruments
Teaching Hospitals
Observational Studies
Referral and Consultation
Prospective Studies

Keywords

  • Cervical cancer
  • Cervical cancer screening
  • Limited resource setting
  • Rwanda
  • Visual inspection with acetic acid

Cite this

Cervical cancer screening at a tertiary care center in Rwanda. / Ruzigana, George; Bazzet-Matabele, Lisa; Rulisa, Stephen; Martin, Allison N.; Ghebre, Rahel G.

In: Gynecologic Oncology Reports, Vol. 21, 01.08.2017, p. 13-16.

Research output: Contribution to journalArticle

Ruzigana, George ; Bazzet-Matabele, Lisa ; Rulisa, Stephen ; Martin, Allison N. ; Ghebre, Rahel G. / Cervical cancer screening at a tertiary care center in Rwanda. In: Gynecologic Oncology Reports. 2017 ; Vol. 21. pp. 13-16.
@article{f2d135bc100e44c8be33e64023f7131a,
title = "Cervical cancer screening at a tertiary care center in Rwanda",
abstract = "In limited resource settings such as Rwanda, visual inspection with acetic acid (VIA) is the primary model for cervical cancer screening. The objective of this study was to describe clinical characteristics and outcomes for women presenting for cervical cancer screening. A prospective, observational study was conducted between September 2015 and February 2016 at Kigali University Teaching Hospital (CHUK). Women referred to the VIA clinic were enrolled and completed a semi-structured questionnaire. During the six-month study period, 150 women were enrolled and evaluated with VIA followed by colposcopy directed biopsy for VIA positive. The median age was 42 years (IQR 36–49). Only 20 (13.3{\%}) asymptomatic women presented for screening exam, whereas 126 (84{\%}) were symptomatic. Among symptomatic patients, more than one-third had never had a speculum exam prior to referral (n = 43). Twenty-two (14.7{\%}) women were VIA positive, and 8 (5.3{\%}) had lesions suspicious for cancer, while 120 (80{\%}) were found to be VIA negative. Among women undergoing biopsy (n = 30), 11 were normal (36.7{\%}), 5 cases showed CIN 1 (16.6{\%}), 4 cases showed CIN 2 (13.3{\%}), 2 cases showed CIN 3 (6.7{\%}) and 8 were confirmed cervical cancers (26.7{\%}). In Rwanda, VIA is the current method for cervical cancer screening. In this study, few asymptomatic patients presented for cervical cancer screening. Increasing knowledge about cervical cancer screening and expanding access are key elements to improving cervical cancer control in Rwanda.",
keywords = "Cervical cancer, Cervical cancer screening, Limited resource setting, Rwanda, Visual inspection with acetic acid",
author = "George Ruzigana and Lisa Bazzet-Matabele and Stephen Rulisa and Martin, {Allison N.} and Ghebre, {Rahel G}",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.gore.2017.05.005",
language = "English (US)",
volume = "21",
pages = "13--16",
journal = "Gynecologic Oncology Reports",
issn = "2211-338X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Cervical cancer screening at a tertiary care center in Rwanda

AU - Ruzigana, George

AU - Bazzet-Matabele, Lisa

AU - Rulisa, Stephen

AU - Martin, Allison N.

AU - Ghebre, Rahel G

PY - 2017/8/1

Y1 - 2017/8/1

N2 - In limited resource settings such as Rwanda, visual inspection with acetic acid (VIA) is the primary model for cervical cancer screening. The objective of this study was to describe clinical characteristics and outcomes for women presenting for cervical cancer screening. A prospective, observational study was conducted between September 2015 and February 2016 at Kigali University Teaching Hospital (CHUK). Women referred to the VIA clinic were enrolled and completed a semi-structured questionnaire. During the six-month study period, 150 women were enrolled and evaluated with VIA followed by colposcopy directed biopsy for VIA positive. The median age was 42 years (IQR 36–49). Only 20 (13.3%) asymptomatic women presented for screening exam, whereas 126 (84%) were symptomatic. Among symptomatic patients, more than one-third had never had a speculum exam prior to referral (n = 43). Twenty-two (14.7%) women were VIA positive, and 8 (5.3%) had lesions suspicious for cancer, while 120 (80%) were found to be VIA negative. Among women undergoing biopsy (n = 30), 11 were normal (36.7%), 5 cases showed CIN 1 (16.6%), 4 cases showed CIN 2 (13.3%), 2 cases showed CIN 3 (6.7%) and 8 were confirmed cervical cancers (26.7%). In Rwanda, VIA is the current method for cervical cancer screening. In this study, few asymptomatic patients presented for cervical cancer screening. Increasing knowledge about cervical cancer screening and expanding access are key elements to improving cervical cancer control in Rwanda.

AB - In limited resource settings such as Rwanda, visual inspection with acetic acid (VIA) is the primary model for cervical cancer screening. The objective of this study was to describe clinical characteristics and outcomes for women presenting for cervical cancer screening. A prospective, observational study was conducted between September 2015 and February 2016 at Kigali University Teaching Hospital (CHUK). Women referred to the VIA clinic were enrolled and completed a semi-structured questionnaire. During the six-month study period, 150 women were enrolled and evaluated with VIA followed by colposcopy directed biopsy for VIA positive. The median age was 42 years (IQR 36–49). Only 20 (13.3%) asymptomatic women presented for screening exam, whereas 126 (84%) were symptomatic. Among symptomatic patients, more than one-third had never had a speculum exam prior to referral (n = 43). Twenty-two (14.7%) women were VIA positive, and 8 (5.3%) had lesions suspicious for cancer, while 120 (80%) were found to be VIA negative. Among women undergoing biopsy (n = 30), 11 were normal (36.7%), 5 cases showed CIN 1 (16.6%), 4 cases showed CIN 2 (13.3%), 2 cases showed CIN 3 (6.7%) and 8 were confirmed cervical cancers (26.7%). In Rwanda, VIA is the current method for cervical cancer screening. In this study, few asymptomatic patients presented for cervical cancer screening. Increasing knowledge about cervical cancer screening and expanding access are key elements to improving cervical cancer control in Rwanda.

KW - Cervical cancer

KW - Cervical cancer screening

KW - Limited resource setting

KW - Rwanda

KW - Visual inspection with acetic acid

UR - http://www.scopus.com/inward/record.url?scp=85019995120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019995120&partnerID=8YFLogxK

U2 - 10.1016/j.gore.2017.05.005

DO - 10.1016/j.gore.2017.05.005

M3 - Article

VL - 21

SP - 13

EP - 16

JO - Gynecologic Oncology Reports

JF - Gynecologic Oncology Reports

SN - 2211-338X

ER -